JP2019147801A5 - - Google Patents

Download PDF

Info

Publication number
JP2019147801A5
JP2019147801A5 JP2019067955A JP2019067955A JP2019147801A5 JP 2019147801 A5 JP2019147801 A5 JP 2019147801A5 JP 2019067955 A JP2019067955 A JP 2019067955A JP 2019067955 A JP2019067955 A JP 2019067955A JP 2019147801 A5 JP2019147801 A5 JP 2019147801A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
sequence
acid sequence
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019067955A
Other languages
English (en)
Japanese (ja)
Other versions
JP6732990B2 (ja
JP2019147801A (ja
Filing date
Publication date
Priority claimed from GBGB1114858.2A external-priority patent/GB201114858D0/en
Application filed filed Critical
Publication of JP2019147801A publication Critical patent/JP2019147801A/ja
Publication of JP2019147801A5 publication Critical patent/JP2019147801A5/ja
Application granted granted Critical
Publication of JP6732990B2 publication Critical patent/JP6732990B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019067955A 2011-05-06 2019-03-29 抗神経成長因子抗体並びに前記抗体の製造及び使用方法 Active JP6732990B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201161483481P 2011-05-06 2011-05-06
US61/483,481 2011-05-06
GBGB1114858.2A GB201114858D0 (en) 2011-08-29 2011-08-29 Anti-nerve growth factor antibodies and methods of using the same
GB1114858.2 2011-08-29
US201161531439P 2011-09-06 2011-09-06
US61/531,439 2011-09-06

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017031939A Division JP2017101064A (ja) 2011-05-06 2017-02-23 抗神経成長因子抗体並びに前記抗体の製造及び使用方法

Publications (3)

Publication Number Publication Date
JP2019147801A JP2019147801A (ja) 2019-09-05
JP2019147801A5 true JP2019147801A5 (enExample) 2019-10-24
JP6732990B2 JP6732990B2 (ja) 2020-07-29

Family

ID=50931152

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2015239920A Active JP5969102B2 (ja) 2011-05-06 2015-12-09 治療用イヌ免疫グロブリンおよびそれを用いる方法
JP2017031939A Pending JP2017101064A (ja) 2011-05-06 2017-02-23 抗神経成長因子抗体並びに前記抗体の製造及び使用方法
JP2019067955A Active JP6732990B2 (ja) 2011-05-06 2019-03-29 抗神経成長因子抗体並びに前記抗体の製造及び使用方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2015239920A Active JP5969102B2 (ja) 2011-05-06 2015-12-09 治療用イヌ免疫グロブリンおよびそれを用いる方法
JP2017031939A Pending JP2017101064A (ja) 2011-05-06 2017-02-23 抗神経成長因子抗体並びに前記抗体の製造及び使用方法

Country Status (3)

Country Link
US (3) US9580496B2 (enExample)
JP (3) JP5969102B2 (enExample)
GB (1) GB2528401A (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8587771B2 (en) * 2010-07-16 2013-11-19 Microsoft Corporation Method and system for multi-phase dynamic calibration of three-dimensional (3D) sensors in a time-of-flight system
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
ES2746805T3 (es) * 2013-12-12 2020-03-06 Shanghai hengrui pharmaceutical co ltd Anticuerpo de PD-1, fragmento de unión a antígeno del mismo y aplicación médica del mismo
CA2932515C (en) 2013-12-20 2023-08-01 Intervet International B.V. Caninized antibodies
US9725710B2 (en) 2014-01-08 2017-08-08 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
EP3201230B1 (en) 2014-09-30 2020-12-23 Intervet International B.V. Pd-l1 antibodies binding canine pd-l1
US9758575B2 (en) * 2015-04-06 2017-09-12 Yung Shin Pharmaceutical Industrial Co. Ltd. Antibodies which specifically bind to canine vascular endothelial growth factor and uses thereof
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
CA2995849A1 (en) * 2015-08-31 2017-03-09 The Trustees Of The University Of Pennsylvania Chimeric aav-anti-vegf for treating cancer in canines
WO2017102920A1 (en) 2015-12-18 2017-06-22 Intervet International B.V. Caninized human antibodies to human and canine il-4r alpha
US11091556B2 (en) 2015-12-18 2021-08-17 Intervet Inc. Caninized human antibodies to human IL-4R alpha
WO2017119435A1 (ja) 2016-01-06 2017-07-13 株式会社オーダーメードメディカルリサーチ 高親和性抗vegf抗体
KR102293753B1 (ko) 2016-01-06 2021-08-24 오더-메이드 메디컬 리서치 인코포레이티드 Vegf 와 nrp1 의 결합을 저해하는 항체
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US10928489B2 (en) * 2017-04-06 2021-02-23 Microsoft Technology Licensing, Llc Time of flight camera
US10215856B1 (en) 2017-11-27 2019-02-26 Microsoft Technology Licensing, Llc Time of flight camera
US10901087B2 (en) 2018-01-15 2021-01-26 Microsoft Technology Licensing, Llc Time of flight camera
US10942274B2 (en) 2018-04-11 2021-03-09 Microsoft Technology Licensing, Llc Time of flight and picture camera
US10895925B2 (en) 2018-10-03 2021-01-19 Microsoft Technology Licensing, Llc Touch display alignment
US11435476B2 (en) 2018-10-12 2022-09-06 Microsoft Technology Licensing, Llc Time-of-flight RGB-IR image sensor
JP2021059499A (ja) 2019-10-03 2021-04-15 日本全薬工業株式会社 イヌcd20に対するモノクローナル抗体又は抗体フラグメント
US11079515B2 (en) 2019-12-18 2021-08-03 Microsoft Technology Licensing, Llc Micro lens time-of-flight sensor having micro lens heights that vary based on image height
WO2023004784A1 (zh) 2021-07-30 2023-02-02 成都优洛生物科技有限公司 一种重组cho细胞、其构建方法、利用其的检测系统和方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2837240B2 (ja) * 1990-06-07 1998-12-14 財団法人化学及血清療法研究所 イヌ免疫グロブリンγ鎖の定常領域をコードする遺伝子断片およびマウス×イヌキメラ抗体
GB9202796D0 (en) 1992-02-11 1992-03-25 Wellcome Found Antiviral antibody
EP1268794A2 (en) 2000-04-07 2003-01-02 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors
US7321026B2 (en) 2001-06-27 2008-01-22 Skytech Technology Limited Framework-patched immunoglobulins
US20030190705A1 (en) 2001-10-29 2003-10-09 Sunol Molecular Corporation Method of humanizing immune system molecules
EP1485126A4 (en) 2001-12-21 2007-03-21 Idexx Lab Inc DOG IMMUNOGLOBULIN VARIABLE DOMAINS, DOG ANTIBODIES, AND METHOD FOR THEIR PRODUCTION AND USE
BRPI0407375A (pt) * 2003-02-19 2006-02-07 Rinat Neuroscience Corp Métodos para tratar dor por meio da administração de um antagonista do fator de crescimento neural e u nsaid e composições contendo os mesmos
JP2005104936A (ja) * 2003-10-01 2005-04-21 Nippon Zenyaku Kogyo Kk イヌtarc抗体
JP2005143436A (ja) * 2003-11-18 2005-06-09 Nippon Zenyaku Kogyo Kk イヌmdc
ITRM20030601A1 (it) 2003-12-24 2005-06-25 Lay Line Genomics Spa Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti.
US7462697B2 (en) * 2004-11-08 2008-12-09 Epitomics, Inc. Methods for antibody engineering
ITRM20050290A1 (it) 2005-06-07 2006-12-08 Lay Line Genomics Spa Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
MX367012B (es) * 2007-06-01 2019-08-02 Univ Maryland Agentes de union al receptor de la region constante fc de inmunoglobulina.
US8337842B2 (en) 2008-09-04 2012-12-25 Vet Therapeutics, Inc. Monoclonal antibodies
US8569460B2 (en) 2009-03-25 2013-10-29 Vet Therapeutics, Inc. Antibody constant domain regions and uses thereof
WO2010117448A2 (en) 2009-04-05 2010-10-14 Provenance Biopharmaceuticals Corp. Chimeric immunocytokines and methods of use thereof
JP6121903B2 (ja) 2010-08-19 2017-04-26 ゾエティス・ベルジャム・エス・アー 抗ngf抗体およびその使用
CN103732621B (zh) 2011-05-06 2020-04-24 內克斯威特澳大利亚私人有限公司 抗神经生长因子抗体及其制备和使用方法

Similar Documents

Publication Publication Date Title
JP2019147801A5 (enExample)
JP2014522236A5 (enExample)
JP7041516B2 (ja) 共通軽鎖を有する二重特異性抗体又は抗体混合物
JP2014519317A5 (enExample)
JP2020514277A5 (enExample)
RU2016129113A (ru) Антитела к pd-1 собак
JP2014519318A5 (enExample)
JP2020536532A5 (enExample)
JP2019536806A5 (enExample)
JP2020537644A5 (enExample)
JP2016536322A5 (enExample)
RU2019111722A (ru) Антитела против siglec-15 и способы их применения
RU2019121086A (ru) Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1)
JP2018521638A5 (enExample)
WO2016207304A3 (en) Monoclonal anti-il-1racp antibodies
JP2016020389A5 (enExample)
FI3484915T3 (fi) Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä
JP2014511179A5 (enExample)
RU2017134495A (ru) Антитела к альфа-рецептору собачьего интерлейкина-4
JP2015503909A5 (enExample)
JP2017052784A5 (enExample)
JP2011509245A5 (enExample)
CN102702358A (zh) 针对csf-1r的抗体
JP2016507470A5 (enExample)
JP2010526028A5 (enExample)